Normal Modes Expose Active Sites in Enzymes

por Glantz-Gashai, Yitav, Meirson, Tomer, Samson, Abraham O.
Publicado 2016

An in silico high-throughput screen identifies potential selective inhibitors for the non-receptor tyrosine kinase Pyk2

por Meirson, Tomer, Samson, Abraham O, Gil-Henn, Hava
Publicado 2017

Safety of BRAF+MEK Inhibitor Combinations: Severe Adverse Event Evaluation

por Meirson, Tomer, Asher, Nethanel, Bomze, David, Markel, Gal
Publicado 2020

Associating liver partition and portal vein ligation or combined transarterial chemo-embolisation and portal vein embolisation for staged hepatectomy for HBV-related hepatocellular...

por Gavriilidis, Paschalis, Pawlik, Timothy M., Meirson, Tomer, Azoulay, Daniel
Publicado 2023

Virtual screening for potential inhibitors of Mcl-1 conformations sampled by normal modes, molecular dynamics, and nuclear magnetic resonance

por Glantz-Gashai, Yitav, Meirson, Tomer, Reuveni, Eli, Samson, Abraham O
Publicado 2017

Systemic review of the robustness of randomized controlled trials for the treatment of cholangiocarcinoma in three domains: survival-inferred fragility index, restricted mean survi...

por Horesh, Nir, Bomze, David, Lim, Chetana, Markel, Gal, Meirson, Tomer, Azoulay, Daniel
Publicado 2022

Systemic structural analysis of alterations reveals a common structural basis of driver mutations in cancer

por Meirson, Tomer, Bomze, David, Schueler-Furman, Ora, Stemmer, Salomon M, Markel, Gal
Publicado 2023

Intracerebroventricular Administration of L-arginine Improves Spatial Memory Acquisition in Triple Transgenic Mice Via Reduction of Oxidative Stress and Apoptosis

por Fonar, Gennadiy, Polis, Baruh, Meirson, Tomer, Maltsev, Alexander, Elliott, Evan, Samson, Abraham O.
Publicado 2018

Oral inflammation promotes oral squamous cell carcinoma invasion

por Goertzen, Cameron, Mahdi, Hayder, Laliberte, Catherine, Meirson, Tomer, Eymael, Denise, Gil-Henn, Hava, Magalhaes, Marco
Publicado 2018

Survival-Inferred Fragility Index of Phase 3 Clinical Trials Evaluating Immune Checkpoint Inhibitors

por Bomze, David, Asher, Nethanel, Hasan Ali, Omar, Flatz, Lukas, Azoulay, Daniel, Markel, Gal, Meirson, Tomer
Publicado 2020

Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience

por Asher, Nethanel, Israeli-Weller, Noa, Shapira-Frommer, Ronnie, Ben-Betzalel, Guy, Schachter, Jacob, Meirson, Tomer, Markel, Gal
Publicado 2021

Assessment of Median and Mean Survival Time in Cancer Clinical Trials

por Das, Ananya, Lin, Timothy A., Lin, Christine, Meirson, Tomer, McCaw, Zachary R., Tian, Lu, Ludmir, Ethan B.
Publicado 2023

Pyk2 and FAK differentially regulate invadopodia formation and function in breast cancer cells

por Genna, Alessandro, Lapetina, Stefanie, Lukic, Nikola, Twafra, Shams, Meirson, Tomer, Sharma, Ved P., Condeelis, John S., Gil-Henn, Hava
Publicado 2018

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma

por Asher, Nethanel, Ben-Betzalel, Guy, Lev-Ari, Shaked, Shapira-Frommer, Ronnie, Steinberg-Silman, Yael, Gochman, Neta, Schachter, Jacob, Meirson, Tomer, Markel, Gal
Publicado 2020

Trends in Women’s Leadership of Oncology Clinical Trials

por Waldhorn, Ithai, Dekel, Ayelet, Morozov, Anna, Alon, Elisa Sardas, Stave, Danielle, Tsrooya, Noam Ben, Schlosser, Shir, Markel, Gal, Bomze, David, Meirson, Tomer
Publicado 2022

Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors

por Meirson, Tomer, Genna, Alessandro, Lukic, Nikola, Makhnii, Tetiana, Alter, Joel, Sharma, Ved P., Wang, Yarong, Samson, Abraham O., Condeelis, John S., Gil-Henn, Hava
Publicado 2018

Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma

por Meirson, Tomer, Pentimalli, Francesca, Cerza, Francesco, Baglio, Giovanni, Gray, Steven G., Correale, Pierpaolo, Krstic-Demonacos, Marija, Markel, Gal, Giordano, Antonio, Bomze, David, Mutti, Luciano
Publicado 2022

Tumor cell density regulates matrix metalloproteinases for enhanced migration

por Jayatilaka, Hasini, Umanzor, Fatima G., Shah, Vishwesh, Meirson, Tomer, Russo, Gabriella, Starich, Bartholomew, Tyle, Pranay, Lee, Jerry S.H, Khatau, Shyam, Gil-Henn, Hava, Wirtz, Denis
Publicado 2018

Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy

por Nissani, Abraham, Lev-Ari, Shaked, Meirson, Tomer, Jacoby, Elad, Asher, Nethanel, Ben-Betzalel, Guy, Itzhaki, Orit, Shapira-Frommer, Ronnie, Schachter, Jacob, Markel, Gal, Besser, Michal J.
Publicado 2021

Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology

por Meirson, Tomer, Nardone, Valerio, Pentimalli, Francesca, Markel, Gal, Bomze, David, D’Apolito, Maria, Correale, Pierpaolo, Giordano, Antonio, Pirtoli, Luigi, Porta, Camillo, Gray, Steven G, Mutti, Luciano
Publicado 2022